Movement Disorders and Parkinson's Disease

The Movement Disorders research program is focused on clinically relevant research that will lead to improved patient care and to enhance quality of life of patients with Parkinson’s and other movement disorders.

Current initiatives include undertaking to investigate the prevalence and impact on quality of life of pain syndromes in Parkinson’s disease, the role of continuous dopaminergic stimulation in reducing the incidence of the neurobehavioral effects of medications, the development of a deep brain stimulator program for the management of Parkinson patients and other movement disorders, and enhanced care of patients with a variety of spasticity disorders.

Parkinson’s Disease Research

A project is currently being established in collaboration with Assoc Prof Stephen Gibson of National Aging Research Institute and Dr Michael Farrell of the Howard Florey Institute to examine the impact of pain on quality of life and functioning in Parkinson’s disease.  In a separate study, the effect of continuous dopaminergic stimulation on other non-motor symptoms in Parkinson’s patients will be examined.

In addition the phenomenology, neurobiology, impact on quality of life and management of movement disorders that occur with multiple sclerosis will be examined in a longitudinal study. 

In a separate study the role of physiotherapy and triggers for seeking treatment in patients with dystonia will be examined.

Yes, I want to fight against movement disorders and make a donation.